Exercise as medicine: could cardiac rehab ease a double Heart-Lung condition?

NCT ID NCT04909008

Terminated Symptom relief Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether 10 weeks of supervised exercise training can improve heart function, oxygen use, and quality of life in people with heart failure and pulmonary hypertension. Forty participants will do three sessions per week at a cardiac rehab clinic. The goal is to see if exercise can lower lung blood pressure and boost exercise capacity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: supervised exercise training (cardiac rehab)
What this could lead to: If it works, this could point toward a drug-free way to improve heart function and daily life for people with heart failure and pulmonary hypertension.
What could go wrong: This is a small, early-phase study with only 40 participants, and it is currently suspended. Exercise may not improve heart pressures or oxygen uptake as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure pulmonary hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE PULMONARY HYPERTENSION

Contacts and locations

Locations

Mayo Clinic in Florida

Jacksonville, Florida, 32224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.